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Introduction: Influenza-associated severe acute respiratory infections (SARI) are a major contributor to global morbidity and 
for influenza A(H1N1)pdm09, an investigation was initiated to determine whether there was an increase of paediatric SARI 
diagnoses compatible with SARI.
months (Interquartile range: 2–14 months). Children aged less than 5 years had a higher rate of paediatric SARI 
1.7 [95% CI: 1.1–2.6]). This increase was not observed in children aged 5–14 years. The case-fatality ratio was not 
Conclusion: The investigation enabled targeted public health response measures, including enhanced SARI surveillance at 
mortality. In response to a cluster of SARI cases and deaths in pregnant women, with two deceased cases testing positive 
cases admitted to divisional hospital intensive care units in Fiji in may 2016 compared to May 2013–2015.
Methods: Retrospective case finding was conducted at the paediatric intensive care units (PICUs) in Fiji’s three divisional
hospitals. Data were collected from 1 January 2013 to 26 May 2016. Cases were identified using a list of clinical 
Results: A total of 632 cases of paediatric SARI with complete details were identified. The median age of cases was 
6
requiring admission to a divisional hospital PICU in May 2016 compared to May 2013–2015 (Incidence rate ratio: 
significantly different in 2016 compared to previous years.
divisional hospitals and an emergency influenza vaccination campaign in the Northern Division.
Influenza-associated severe acute respiratory infections (SARI) are a major contributor to global morbidity and mortality, particularly among high-risk groups such 
as pregnant women and children. In 2008, the World 
Health Organization (WHO) estimated that there were 
90 million new cases of seasonal influenza globally and 
20 million cases of influenza-associated acute lower 
respiratory infections in children less than 5 years.1 
Influenza outbreaks typically occur during winter months 
in countries with temperate climates. In Pacific island 
countries, influenza outbreaks can occur throughout the 
year with less seasonal variation.2 Influenza vaccination 
is an effective method for the prevention of influenza 
infection and subsequent complications.3 WHO 
recommends influenza vaccination for pregnant women 
and children aged 6 months to 5 years to prevent severe 
disease requiring hospitalization.1
Fiji is a tropical archipelago in the South Pacific 
Ocean with an estimated population of 865 611.4 
National surveillance systems in Fiji capture information 
on influenza-like illness; however, surveillance for SARI is 
limited.5 Fiji does not currently have a seasonal influenza 
vaccination policy; however, vaccination is recommended 
for high-risk groups including health-care workers, 
pregnant women, elderly persons and those with chronic 
illnesses.3 Influenza vaccination is not publicly funded 
under Fiji’s national immunization programme, yet 
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2015. The frequency and proportion of SARI cases were 
tabulated with a further breakdown of age for children 
less than 5 years (0–5 months, 6–11 months, 12–23 
months, 24–35 months, 36–47 months and 48–59 
months) as well as the 5–9 year and 10–14 year age 
categories. Case-fatality ratios (CFRs) were calculated 
for January–May 2016 and January–May 2013–2015. 
A Fisher’s exact two-sided p-value was calculated to 
compare the 2016 and baseline case-fatality ratios. The 
month of May 2016 in this paper refers to data collected 
up to 26 May 2016 (date of the investigation); data were 
collected and analysed for whole months in prior years. 
All analyses were conducted using Stata 14.1 (StataCorp 
LP, College Station, USA) and Microsoft Excel 2016 
(Microsoft Corporation, Redmond, USA).
RESULTS
We identified 632 cases of paediatric SARI with complete 
details requiring admission to divisional hospital PICUs 
between January 2013 and May 2016 (Fig. 1). The median 
age of paediatric SARI cases during the investigation period 
(January 2013–May 2016) was 6 months (Interquartile 
range: [IQR] 2–14 months). Ninety-three per cent 
(n = 586) of all cases identified during the investigation 
were in children aged less than 5 years. Moreover, 85% 
(n = 540) were in children aged less than 2 years.
Fig. 1 shows the number of cases admitted by month 
and year of the investigation period. The rate of paediatric 
SARI in children less than 5 years was higher during the 
month of May 2016 when compared to the same period 
in 2013–2015 (IRR: 1.7 [95% CI: 1.1–2.6]) (Table 1). 
The rate increase in children less than 5 years was not 
statistically significant when stratified by division (Table 1).
The CFRs were not significantly different for cases of 
paediatric SARI requiring admission to divisional hospital 
PICUs in January–May 2016 (12.5%) compared to the 
same period in 2013–2015 (9.1%) (P = 0.343).
Outbreak response
The FCCDC established enhanced SARI surveillance at 
divisional hospital PICUs to ensure continued monitoring. 
In addition, the FCCDC, with support from the WHO 
Emerging Diseases Clinical Assessment and Response 
Network, conducted critical care training with a particular 
focus on SARI for PICU staff in August 2016.
vaccines may be purchased privately from health-care 
providers.6 Uptake of the influenza vaccine in Fiji has 
previously been reported as low.7
In May 2016, the Ministry of Health and Medical 
Services (MoHMS) in Fiji identified an increase in adult 
hospital admissions due to severe respiratory infections. 
In addition, a small cluster of pregnant women developed 
SARI, four of whom died. Two of the four deceased cases 
tested positive for the influenza A(H1N1)pdm09 virus.8 
In response to the increased SARI activity in adults, an 
investigation was conducted to determine if there was an 
increase in paediatric SARI cases requiring admission to 
divisional hospital paediatric intensive care units (PICUs) 
in Fiji in May 2016 compared to May 2013–2015 
and to implement appropriate control measures. The 
investigation was led by the Fiji Centre for Communicable 
Disease Control (FCCDC) with support by WHO. This 
paper reports the findings of the investigation.
METHODS
We conducted retrospective case finding on 26–27 May 
2016 at the three divisional hospital PICUs in Fiji: Colonial 
War Memorial Hospital (covering Central and Eastern 
Divisions), Labasa Divisional Hospital (Northern Division) 
and Lautoka Divisional Hospital (Western Division). 
Patient registers were reviewed to identify cases clinically 
compatible with SARI. Data from January 2013 to May 
2016 were collected to ensure sufficient historical data to 
calculate baseline rates of disease.
A case-patient was defined as a child aged 0–14 
years admitted to a divisional hospital PICU from 1 
January 2013 to 26 May 2016 with any of the following 
diagnoses: pneumonia, severe pneumonia, acute 
respiratory distress syndrome, influenza, lower respiratory 
tract infection, upper respiratory tract infection or severe 
acute respiratory infection.
Data were collected on patients’ date of admission, 
age, diagnosis and outcome. Population data were 
calculated by applying estimated growth rates to 2007 
Fiji census data.9 Incidence rates were calculated for 
the month of May by division and paediatric age groups 
available from the census data (0–4 years, 5–9 years 
and 10–14 years). Incidence rate ratios (IRR) and Fisher’s 
exact 95% confidence intervals (CI) were calculated to 
compare incidence rates for May 2016 and May 2013–
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Fig. 1. Cases of paediatric severe acute respiratory infection (SARI) admitted to divisional hospital paediatric 
intensive care units (PICUs) by division and month of admission, Fiji, January 2013 to May 2016 
(n = 632)
* Monthly incidence rates were calculated for May in each year.
† Incidence rate ratios could not be calculated for some groups because of zero counts.
CI: confidence interval, IR: incidence rate, and IRR: incidence rate ratio
Table 1. Incidence rate per 10 000 population and incidence rate ratio of paediatric SARI requiring admission 
to divisional hospital PICUs, Fiji, May 2016 and May 2013–2015
 May 2016 May 2013–2015  
 IR* IR* IRR (95% CI)†
Central/Eastern Division   
0–4 years 5.6 3.5 1.6 (0.9–2.7)
5–9 years 0.3 0.2 1.5 (0.0–28.2)
10–14 years 0.2 - -
Western Division
0–4 years 2.2 1.3 1.7 (0.6–4.8)
5–9 years - 0.2 -
10–14 years - - -
Northern Division
0–4 years 2.9 1.2 2.4 (0.5–11.2)
5–9 years - - -
10–14 years - - -
Divisions combined   
0–4 years 4.0 2.3 1.7 (1.1–2.6)
5–9 years 0.1 0.2 0.7 (0.0–7.5)
10–14 years 0.1 - -
All years (0–14) 1.4 0.9 1.7 (1.1–2.6)
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Several limitations were identified in the 
investigation. We only measured severe disease requiring 
admission to paediatric intensive care units; this paper 
does not provide a comprehensive estimate of paediatric 
SARI incidence. The investigation case definition was 
based on clinical diagnoses, which may have resulted 
in some misclassification of SARI cases. The etiology of 
SARI was not systematically investigated as suspected 
cases of influenza are not routinely confirmed by 
microbiological testing in Fiji; the assumption that the 
increase in paediatric SARI was due to influenza cannot 
be confirmed. CFRs should be interpreted in the context 
of PICU admissions rather than all paediatric SARI 
hospitalizations. Since the investigation was conducted 
in May 2016, CFRs were calculated for the period 
January–May for each year (2013–2016) and incidence 
rates for the month of May only (2013–2016). Small 
case numbers in some divisions and age groups may 
have influenced the results.
While recognizing there are competing priorities for 
health resources, the introduction of a seasonal influenza 
vaccination policy for high-risk groups, as per WHO 
recommendations, should be considered to address the 
ongoing burden of paediatric SARI in Fiji.1,3
CONCLUSION
This investigation provided valuable information on 
the burden of paediatric SARI requiring admission to 
divisional hospital PICUs in Fiji in May 2016. The data 
were used to implement targeted public health response 
measures and enhance surveillance for paediatric SARI in 
divisional hospitals in Fiji.
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DISCUSSION
We found that children aged less than 5 years experienced 
a higher rate of SARI requiring admission to divisional 
hospital PICUs in the month of May 2016 compared to 
the same month in 2013–2015. The majority of SARI 
cases in the investigation period occurred in children 
aged less than 2 years (85%), which confirms that this 
age group is at a high risk of severe influenza-associated 
respiratory infections.1,10
Three months before the outbreak, Fiji was struck 
by one of the strongest tropical cyclones recorded in 
the southern hemisphere. Tropical Cyclone Winston 
resulted in 44 deaths and caused severe damage and 
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